EGM
NRIX icon

Engineers Gate Manager’s Nurix Therapeutics NRIX Stock Holding History

Engineers Gate Manager’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,492
Closed -$171K – 2400
2025
Q3 		$171K Sell
18,492
-15,784
-46% -$164K ﹤0.01% 1936
2025
Q2 		$390K Sell
34,276
-18,284
-35% -$198K ﹤0.01% 1595
2025
Q1 		$624K Buy
+52,560
New +$879K 0.01% 1335
2024
Q4 		– Sell
-24,975
Closed -$561K – 2471
2024
Q3 		$561K Buy
24,975
+423
+2% +$9.58K 0.01% 1323
2024
Q2 		$512K Buy
+24,552
New +$382K 0.01% 1209
2024
Q1 		– Sell
-20,514
Closed -$212K – 2184
2023
Q4 		$212K Buy
+20,514
New +$141K 0.01% 1612

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Engineers Gate Manager's NRIX Position: Q4 2025 in Review

Engineers Gate Manager sold out of Nurix Therapeutics (NRIX) in Q4 2025, closing a stake of 18,492 shares — an estimated $171K sold.

Engineers Gate Manager first reported a position in NRIX in Q4 2023 and held it in 6 quarters. The position peaked at $624K in Q1 2025. 182 funds tracked by Wall St. Rank hold NRIX as of Q4 2025.

  • Engineers Gate Manager reported no remaining Nurix Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 18,492 Nurix Therapeutics shares in Q4 2025, an estimated $171K.
  • Engineers Gate Manager first reported a position in Nurix Therapeutics in Q4 2023 and held it in 6 quarters.
  • Engineers Gate Manager's Nurix Therapeutics position peaked at $624K in Q1 2025.
  • 182 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q4 2025.

Based on Engineers Gate Manager's 13F filing for Q4 2025, filed 17 Feb 2026.